Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.

NCT02876900 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

617

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Low Dose Asenapine maleate transdermal patch
DRUG: High Dose Asenapine maleate transdermal patch
DRUG: Placebo

Sponsor

Noven Pharmaceuticals, Inc.